CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia [Phase 2]
Summary
Phase 2 clinical trial evaluating a Helixmith gene therapy for critical limb ischemia has completed, with safety and efficacy results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helixmith Co., Ltd. | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19